Latvia - Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung
Since 2014, Latvia Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung fell by 1.7% year on year. In 2019, the country was ranked number 23 comparing other countries in Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung with 7.7 Days. Latvia is overtaken by Germany, which was ranked number 22 with 8.1 Days and is followed by Austria with 7.4 Days. Costa Rica ranked the highest with 14.1 Days in 2019, that is a growth of 6.8% versus 2018. South Korea, Portugal and Ireland respectively ranked number 2, 3 and 4 in this ranking. Costa Rica witnessed the best average annual growth at +2.8% per year, while Mexico witnessed the worst performance at -6.2% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 7.70 |
| 2018 | 7.60 |
| 2017 | 8.10 |
| 2016 | 8.10 |
| 2015 | 8.00 |
How does Latvia rank in Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Costa Rica
|
14.10 | 2019 | +6.8 % | +2.8 % | View data | |
| 2 |
#2
South Korea
|
13.70 | 2019 | -0.7 % | -0.1 % | View data | |
| 22 |
#22
Germany
|
8.10 | 2019 | -1.2 % | -0.7 % | View data | |
| 23 |
#23
Latvia
|
7.70 | 2019 | +1.3 % | -1.7 % | View data | |
| 24 |
#24
Austria
|
7.40 | 2019 | -2.6 % | +1.1 % | View data | |